Eagle Pharmaceuticals Inc

Eagle Pharmaceuticals, Inc. is a pharmaceutical company focused on manufacturing, developing, and commercializing product candidates for central nervous system diseases, metabolic critical care, and oncology in the United States. Its portfolio includes RYANODEX for malignant hyperthermia; BELRAPZO and BENDEKA for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin's lymphoma; PEMFEXY, a ready-to-dilute liquid form of pemetrexed injection; BARHEMSYS for prevention of postoperative nausea and vomiting; and BYFAVO for procedural sedation in adults. The company has license and collaboration agreements with Combioxin, SA for CAL02, Enalare for ENA-001, and a strategic collaboration with Tyme Technologies, Inc. for SM-88. Eagle Pharmaceuticals was incorporated in 2007 and is headquartered in Woodcliff Lake, New Jersey.